Sign Up to like & get recommendations! 0
Published in 2018 at "Cancer Medicine"
DOI: 10.1002/cam4.1575
Abstract: This study was conducted to assess the efficacy and adverse effects of GP (gemcitabine + cisplatin) regimen and FP (fluouracil + cisplatin) regimen in treatment of advanced nasopharyngeal carcinoma. Systematic online searches were performed in… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3260
Abstract: This study aimed to compare the efficacy and toxicity of raltitrexed (Saiweijian®) plus cisplatin (SP regimen) and 5‐fluorouracil plus cisplatin (FP regimen) as concurrent chemoradiotherapy (CCRT) in patients with locally advanced nasopharyngeal carcinoma (LA‐NPC). read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5497
Abstract: The CSCO and ASCO guidelines in 2021 recommend chemotherapy for stage III–IVA (8th edition of AJCC staging) nasopharyngeal carcinoma (NPC). Actually, patients with stage T3–4N0M0 are often excluded from various clinical trials of the locoregionally… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5707
Abstract: The optimal number of cycles of induction chemotherapy (IC) in locoregionally advanced nasopharyngeal carcinoma (LANPC) remains unresolved. This study aimed to quantitatively assess the changes in gross tumor volumes (GTVs) and to select the most… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30850
Abstract: Concurrent‐adjuvant chemoradiotherapy (CRT) became a recommended treatment for locoregionally advanced nasopharyngeal carcinoma (NPC) with the first report of a significant survival benefit from the Intergroup 0099 study. However, data on late toxicities are lacking. Previous… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer"
DOI: 10.1002/cncr.32972
Abstract: A current recommendation for the treatment of patients with locoregionally advanced nasopharyngeal carcinoma (NPC) is conventional fractionated radiotherapy (RT) with concurrent cisplatin followed by adjuvant cisplatin and 5‐fluorouracil (PF). This randomized NPC‐0501 trial evaluated the… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Journal of Cachexia, Sarcopenia and Muscle"
DOI: 10.1002/jcsm.13196
Abstract: Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) is the standard of care for locoregionally advanced nasopharyngeal carcinoma (LA‐NPC). This intensive treatment regimen increases acute toxicities, which could negatively impact patients' nutritional status. We conducted this… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Oral oncology"
DOI: 10.1016/j.oraloncology.2017.02.026
Abstract: OBJECTIVE To compare the effectiveness of concurrent cisplatin chemoradiotherapy plus cetuximab with that of concurrent chemoradiotherapy (CCRT) alone in locoregionally advanced nasopharyngeal carcinoma (LRANPC) patients. MATERIALS AND METHODS A total of 3257 LRANPC patients from… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-57968-x
Abstract: The TNM staging system of NPC is the most important model for survival prediction. However, this model does not consider the biological variability of the tumor itself. This study aimed to develop a nomogram for… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000027023
Abstract: Abstract Induction chemotherapy (IC) and adjuvant chemotherapy (AC) are used to enhance tumor locoregional control and support early treatment for distant metastases. However, optimum combinatorial treatment of these chemoradiotherapy regimens with radiotherapy in curing locoregionally… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000032732
Abstract: Many locally advanced nasopharyngeal carcinoma patients develop local recurrence or distant metastasis. Our retrospective real-world study aims to evaluate the efficacy and safety of curative sequential approach with induction chemotherapy followed by concurrent chemoradiation + nimotuzumab as… read more here.